
Healthier Capital is a venture capital firm founded by former One Medical CEO Amir Dan Rubin, partnering with technology-powered healthcare innovators to advance healthier outcomes. The firm invests in early-stage health-tech companies leveraging AI and innovative technologies across care delivery, diagnostics, clinical workflows, and life sciences research.
70% of their portfolio is in Healthcare. Deal activity decreased year-over-year (4 deals in the last 12 months vs 6 prior). Their most common stage is series-a (60% of deals). Average disclosed round size is $46.3M (across 17 rounds with reported amounts).
Portfolio
15
Fund Size
$220M
Top Stage
Series A
Last 12 Mo
4
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
20 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | $14M | May 2026 | |
| Series A | $16M | Apr 2026 | |
| Series A | — | Mar 2026 | |
| Series A | $110M | Jan 2026 | |
| Series A | $20M | Sep 2025 | |
| DDaymark | Series A | $20M | Sep 2025 |
| Seed | $30M | Jan 2025 | |
| Seed | $30M | Jan 2025 | |
| DDaymark | Series A | $20M | Jan 2025 |
| Series B | — | Dec 2024 | |
| Series A | $15.5M | Nov 2024 | |
| Series A | $16M | Jul 2024 | |
| Series A | $15M | Apr 2024 | |
| Series A | $15M | Jan 2024 | |
| Series B | $125M | — | |
| Series B | $125M | — | |
| Growth | $45M | — | |
| ZZarminali Health | Series A | $80M | — |
| Series E | $90M | — | |
| Series B | — | — |
Top Co-Investors
Flare Capital Partners8 shared
New Enterprise Associates5 shared
SignalFire5 shared
Frist Cressey Ventures5 shared
Index Ventures4 shared
General Catalyst3 shared
The Blue Venture Fund3 shared
Maverick Ventures3 shared
Yosemite3 shared
Oncology Ventures3 shared
Transformation Capital3 shared
Cathay Innovation3 shared
Anthropic3 shared
K2 HealthVentures2 shared
Macquarie Capital2 shared
Liberty Mutual2 shared
Norwest Venture Partners2 shared
Black Opal Ventures2 shared
8VC2 shared
Bling Capital2 shared
Last updated: 20 October 2026